Foresight Diagnostics’ Post

Colorectal cancer (CRC) is the second-deadliest type of cancer in the United States, with over 50 thousand deaths estimated in 2023 alone*. However, 9 out of 10 CRC deaths can be prevented when caught early**. At Polymedco we promote regular screening all year long, and #ColorectalCancerAwarenessMonth is the perfect time to highlight the importance of screening. Learn more about the importance of screening at https://lnkd.in/eMQS4_Uv *Colorectal Cancer Facts & Figures 2023-2025. American Cancer Society. Accessed January 25, 2023. https://lnkd.in/ekWgjzSy **Tepus M, Yau TO. Non-Invasive Colorectal Cancer Screening: An Overview. Gastrointest Tumors. 2020;7(3):62-73. doi:10.1159/000507701

The month of March is #ColorectalCancerAwarenessMonth and it is a great time to remind everyone 45 – 75 at average risk to get screened.*** At Polymedco, we offer a simple, clinically proven, cost-effective, non-invasive test. Read more here: *US Preventative Services Task Force, Davidson KW, Barry MJ, et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(19):1965-1977. doi:10.1001/jama.2021.6238 **Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG Clinical Guidelines: Colorectal Cancer Screening 2021. Am J Gastroenterol. 2021;116(3):458-479. doi:10.14309/ajg.000000000000122 ***Rex DK, Boland CR, Dominitz JA, et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112(7):1016-1030. doi:10.1038/ ajg.2017.174

METASTATIC CANCER Metastatic cancer refers to cancer that has spread beyond the point of origin to other distant areas of the body. Metastasis is a word used to describe the spread of cancer. Unlike normal cells, cancer cells have the ability to grow outside of the place in your body where. they originated. When this happens, it's called metastatic cancer, advanced cancer or Stage IV cancer. The most common sites for cancers to metastasize include the lungs, liver, bones and brain. Other places include the adrenal gland, lymph nodes, skin and other organs. Some people will have minimal or no symptoms of metastatic cancer. In most cases, metastatic cancer is not curable. However, treatment can slow growth and ease many of the associated symptoms. #snsinstitutions #snsdesignthinking #snsdesignthinkers

Did you know? 🧠 Lung cancer remains a leading cause of cancer-related deaths worldwide. Differentiating between subtypes of non-small-cell lung cancer (NSCLC) is crucial for treatment. Recent findings highlight how cytomorphological features from bronchoscopic brushing samples can help distinguish between adenocarcinoma (ADC) and squamous cell carcinoma (SCC). Small cell clusters and large nuclei are more common in ADCs, while large clusters and small nuclei are typical of SCCs. This research strengthens the role of cytology in accurate cancer subtyping and personalized therapy! 🔬 Read more in Gardić NG, Miljković DM, Lovrenski AN. Cytomorphological features as a subtyping tool of non‐small‐cell lung cancer in brushing bronchoscopic samples. J Cytol 2024;41:143‐9. #LungCancer #Cytopathology #CancerDiagnosis

Lung cancer is the third most common type of cancer diagnosis in the U.S. It arises from the rapid, uncontrolled growth of lung cells. The two main types of lung cancer are small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). SCLC constitutes 10-15% of all lung cancer cases. Understanding the different cancer types is vital for effective diagnosis and treatment. #LungCancerAwareness #HealthEducation #CARO #cancertreatment #radiationoncology

The side effects of cancer treatment are often cited as the more harrowing part of fighting the disease. But thanks to the success of a clinical trial at MUSC Hollings Cancer Center, and a $3.2 million grant from the National Cancer Institute, treatment for certain cancers may come with fewer complications. Brian Hess, M.D., and Shikhar Mehrotra, Ph.D., have partnered on a project to develop “purified” CAR-T cells to treat people with certain B-cell non-Hodgkin lymphomas who have already tried other therapies. CAR-T cell therapy is FDA-approved for certain types of blood cancer, but the Hollings trial is testing a new patented variation that the researchers hope will have longer-lasting results with fewer side effects. #ChangingWhatsPossible Read more: https://lnkd.in/ewBjKec8 #CancerResearch #cancer

NEWS: 'Lung cancer is the deadliest of all cancers, and screening could save many lives − if more people could access it' Informative piece in The Conversation US by pulmonologist Nina Thomas who specializes in screening and diagnosing lung cancer. 'Between 2015 and 2019, survival rates for lung cancer have improved by 22%, in part because of an increase in earlier diagnosis. Most patients with early-stage lung cancer, however, have no symptoms and aren’t diagnosed until they reach more advanced stages that are harder to treat, underlining the need for effective lung cancer screening.' Read the full article here: https://lnkd.in/e6icFEn4 #screening #lungcancerscreening #LungCancerEurope #LuCE #LCSM #cancerscreening

Today is World Lung Cancer Day. This is an annual observance designed to commemorate those who are impacted by lung cancer and raise awareness about lung cancer. Listen to Claire's story which highlights how screening led to early detection and successful treatment of her lung cancer at Regional Hospital of Scranton. Lung screening has the potential to detect lung cancer at earlier stages when it has the best chance of being treated. Commonwealth Health Imaging screens high-risk patients for lung cancer at multiple locations using low-dose CT- https://lnkd.in/dxGMEF-Q

August 1 is World Lung Cancer Day, a day to create awareness about the concerns of lung cancer, promote lung cancer research and create support for those affected by lung cancer. On this day, we hope to educate you about how liquid-biopsy testing is impacting lung cancer treatment management. Liquid biopsy-based blood tests have emerged as a promising non-invasive tool to detect biomarkers to monitor treatment response and guide treatment decisions in patients with lung cancers. Learn more on lung cancer testing and biomarkers: https://hubs.la/Q02JKlH20 #liquidbiopsy #cancer #lungcancerawareness

While a lung cancer diagnosis is never easy, personalized treatment options can offer a beacon of hope.   As research continues to advance, our focus on scientific excellence and innovation is driven by our ambition to help transform the lives of patients everywhere; we’ve dedicated our world-class research capabilities to drive forward more breakthroughs for treating this disease.   On this World Lung Cancer Day, we celebrate the progress that we've made while recognizing there is still more work to be done. Together, we can pave the way for a future where lung cancer is manageable.   In case you missed it, I recently described this precision approach for non-small cell lung cancer in Endpoints News earlier this year. If you’re interested, you can read it here: https://bit.ly/3ymSs4E   #WorldLungCancerDay #LungCancerAwareness #JNJOncology #WLCD24